A Study of an Ad26.RSV.preF-based Vaccine and High-dose Seasonal Influenza Vaccine, With and Without Coadministration, in Adults Aged 65 Years and Older

Clinical trial NCT05071313 · COMPLETED

Trial details

NCT number: NCT05071313
Sponsor: Janssen Vaccines & Prevention B.V.
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Influenza, Human Prevention Respiratory Syncytial Viruses Prevention

Start date: 2021-10-04
Primary completion: 2022-04-20
Enrollment: 777

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.